The increasing prevalence of kidney failure and end-stage renal disease, along with a growing incidence of risk factors like diabetes, hypertension, and aging, is driving the demand for artificial ...

In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of chronic kidney disease in the US ...

Your health care provider can also see how well blood is flowing in your kidneys. A kidney scan is also called a renal scan or renal scintigraphy. A kidney scan is a type of nuclear imaging test. This ...

Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

Semaglutide reduced the risk of kidney disease worsening, renal failure, and CV death by 24% compared ... initiation of chronic kidney replacement therapy (dialysis or kidney transplantation), and ...

This FDA approval is based on results from the FLOW phase 3b ... sustained eGFR < 15 mL/min/1.73 m2, chronic renal replacement therapy, renal death, and CV death in adults with type 2 diabetes and CKD ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...

We are delighted that QUELIMMUNE is now available to treat severely ill children at yet another prominent academic medical center,” said Tim Varacek, SeaStar Medical Senior Vice President, Commercial ...

This approach is claimed to improve organ recovery and potentially eliminate future renal replacement therapy (RRT) requirements, including dialysis. The SCD has also gained FDA breakthrough device ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...